Dupixent 200 mg/1.14mL (Dupilumab INJECTION, SOLUTION) 200 mg/1.14mL

Dupixent 200 mg/1.14mL is a subcutaneous injection solution used for managing moderate-to-severe eczema and other inflammatory conditions. This medication contains dupilumab and is designed for targeted therapy.

Strength

200 mg/1.14mL

Pack Size

2 SYRINGE, GLASS in 1 CARTON (0024-5919-02) / 1.14 mL in 1 SYRINGE, GLASS (0024-5919-00)

Manufacturer / TM Owner

sanofi-aventis U.S. LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dupixent 200 mg/1.14mL is primarily used for the treatment of moderate-to-severe atopic dermatitis (eczema) in adults and children. It may also be prescribed for other inflammatory conditions such as asthma or chronic rhinosinusitis with nasal polyps. Dupilumab works by targeting specific pathways involved in inflammation, helping to reduce symptoms and improve quality of life.

Side Effects

Common effects of Dupixent may include injection site reactions, such as redness or itching. Some users may experience eye-related side effects like conjunctivitis. These effects are generally mild and temporary, but persistent or severe reactions should be discussed with a healthcare provider.

Precautions & Warnings

Dupixent should be stored properly and handled with care to maintain its efficacy. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always check for any signs of contamination or damage to the syringe before use.

Avoid Interactions

Dupixent may interact with other medications, including those that affect the immune system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also influence the effectiveness of Dupixent.

Frequently Asked Questions

Dupixent is used to treat moderate-to-severe atopic dermatitis (eczema) and other inflammatory conditions like asthma or chronic rhinosinusitis with nasal polyps.

Dupixent is administered via subcutaneous injection, typically self-administered or by a caregiver after proper training.

Common side effects include injection site reactions and eye-related issues like conjunctivitis.

Dupixent may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Dupixent should be stored in a refrigerator between 2°C to 8°C (36°F to 46°F) and protected from light.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.